A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Diseases of the nervous system refer to disorders that affect any part of the central nervous system (brain, spinal cord or cranial nerves) or peripheral nervous system. Rabah et al. elegantly ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Aug. 28, 2024 — More than two decades ago, a research team discovered a type of T cell in humans that suppresses the immune system ... Sclerosis Appears to Protect Against Alzheimer's Disease ...

It also develops therapies for various neurological diseases such as amyotrophic lateral sclerosis, multiple sclerosis, traumatic brain injury and chemotherapy-induced peripheral neuropathy. Nura Bio ...

a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS). Under the leadership of Principal Investigator Prof Merit Cudkowicz, MD, Director of the Sean M. Healey ...

(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative and multisystemic disease that limits the quality of life and survival of affected patients. Weight loss, malnutrition, and severe dysphagia ...

Introduction: T regulatory cells (Tregs) inversely correlate with disease progression in Amyotrophic Lateral Sclerosis (ALS ... were analyzed in plasma by Ella Automated Immunoassay System (Simple ...

Central Nervous System Disorders is under clinical development by Neuroplast and currently in Phase I for Amyotrophic Lateral Sclerosis. According to GlobalData, Phase I drugs for Amyotrophic Lateral ...